Clinical Trial Update: Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial) [Phase 3]

View source ↗

Summary

OPC-34712 was studied as adjunctive therapy in adults with major depressive disorder in a Phase 3 trial. The study is completed and results were posted in Novem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder
• Mood Disorders

Drugs mentioned

• OPC-34712

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Depressive Disorder, Depression | Phase 3 | Status: COMPLETED | Results posted: 2015-11-26